Cocrystal Pharma Ownership 2024 | Who Owns Cocrystal Pharma Now?

Overview RevenueFinancials Chart

Institutional Ownership

166.15%

Insider Ownership

30.03%

Retail Ownership

-96.18%

Institutional Holders

22.00

Cocrystal Pharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	4.57%	-	271,445	-	-	540,176,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	2.02%	0.00%	119,828	5,800	5.09%	238,000	Mar 31, 2023
BLACKROCK INC.	1.25%	-	74,063	-	-	147,385,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.17%	-	69,534	-	-	137,677,000	Mar 31, 2023
SABBY MANAGEMENT, LLC	1.11%	0.11%	66,172	-354,538	-84.27%	131,682,000	Mar 31, 2023
MORGAN STANLEY	0.75%	-	44,694	-	-	88,941,000	Mar 31, 2023
STATE STREET CORP	0.41%	-	24,443	-	-	48,397,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.35%	-	20,728	20,728	100.00%	41,041,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.26%	0.00%	15,228	-	-	30,304,000	Mar 31, 2023
NORTHERN TRUST CORP	0.21%	-	12,207	-	-	24,292,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.15%	-	8,975	-16	-0.18%	17,860,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.15%	0.00%	8,651	3,804	78.48%	17,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	1,992	-3,023	-60.28%	3,964,000	Mar 31, 2023
CLEAN YIELD GROUP	0.01%	0.00%	418	-	-	832,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	86	1	1.18%	172,000	Mar 31, 2023
NVWM, LLC	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
ARCHER INVESTMENT CORP	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
FMR LLC	0.00%	-	4	4	100.00%	8,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	2	2	100.00%	4,000	Mar 31, 2023
JPMORGAN CHASE & CO	-	-	-	-260	-100.00%	-	Mar 31, 2023

Cocrystal Pharma's largest institutional shareholder is VANGUARD GROUP INC, holding 4.57% of the company's total share outstanding, currently valued at $540.18M. The top 10 institutional shareholders own together 12.10% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	1.11%	0.11%	66,172	-354,538	-84.27%	131,682,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.26%	0.00%	15,228	-	-	30,304,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.15%	0.00%	8,651	3,804	78.48%	17,000	Mar 31, 2023
CLEAN YIELD GROUP	0.01%	0.00%	418	-	-	832,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	2.02%	0.00%	119,828	5,800	5.09%	238,000	Mar 31, 2023
ARCHER INVESTMENT CORP	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
NVWM, LLC	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.17%	-	69,534	-	-	137,677,000	Mar 31, 2023
VANGUARD GROUP INC	4.57%	-	271,445	-	-	540,176,000	Mar 31, 2023
MORGAN STANLEY	0.75%	-	44,694	-	-	88,941,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.35%	-	20,728	20,728	100.00%	41,041,000	Mar 31, 2023
NORTHERN TRUST CORP	0.21%	-	12,207	-	-	24,292,000	Mar 31, 2023
BLACKROCK INC.	1.25%	-	74,063	-	-	147,385,000	Mar 31, 2023
STATE STREET CORP	0.41%	-	24,443	-	-	48,397,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.15%	-	8,975	-16	-0.18%	17,860,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	1,992	-3,023	-60.28%	3,964,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	86	1	1.18%	172,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	2	2	100.00%	4,000	Mar 31, 2023
FMR LLC	0.00%	-	4	4	100.00%	8,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-18	-100.00%	-	Mar 31, 2023

The largest Cocrystal Pharma shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 66.17K shares of Cocrystal Pharma (COCP), representing 0.11% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.35%	-	20,728	20,728	100.00%	41,041,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	2.02%	0.00%	119,828	5,800	5.09%	238,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.15%	0.00%	8,651	3,804	78.48%	17,000	Mar 31, 2023
FMR LLC	0.00%	-	4	4	100.00%	8,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	2	2	100.00%	4,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	86	1	1.18%	172,000	Mar 31, 2023
STATE STREET CORP	0.41%	-	24,443	-	-	48,397,000	Mar 31, 2023
BLACKROCK INC.	1.25%	-	74,063	-	-	147,385,000	Mar 31, 2023
NORTHERN TRUST CORP	0.21%	-	12,207	-	-	24,292,000	Mar 31, 2023
MORGAN STANLEY	0.75%	-	44,694	-	-	88,941,000	Mar 31, 2023
VANGUARD GROUP INC	4.57%	-	271,445	-	-	540,176,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.17%	-	69,534	-	-	137,677,000	Mar 31, 2023
NVWM, LLC	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
ARCHER INVESTMENT CORP	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
CLEAN YIELD GROUP	0.01%	0.00%	418	-	-	832,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.26%	0.00%	15,228	-	-	30,304,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.15%	-	8,975	-16	-0.18%	17,860,000	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-18	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-18	-100.00%	-	Mar 31, 2023
JPMORGAN CHASE & CO	-	-	-	-260	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, Cocrystal Pharma's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 20.73K stocks of COCP, valued at $41.04M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SABBY MANAGEMENT, LLC	1.11%	0.11%	66,172	-354,538	-84.27%	131,682,000	Mar 31, 2023
UBS GROUP AG	0.03%	-	1,992	-3,023	-60.28%	3,964,000	Mar 31, 2023
JPMORGAN CHASE & CO	-	-	-	-260	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-18	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-18	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.15%	-	8,975	-16	-0.18%	17,860,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.26%	0.00%	15,228	-	-	30,304,000	Mar 31, 2023
CLEAN YIELD GROUP	0.01%	0.00%	418	-	-	832,000	Mar 31, 2023
ARCHER INVESTMENT CORP	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
NVWM, LLC	0.00%	0.00%	84	-	-	167,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	1.17%	-	69,534	-	-	137,677,000	Mar 31, 2023
VANGUARD GROUP INC	4.57%	-	271,445	-	-	540,176,000	Mar 31, 2023
MORGAN STANLEY	0.75%	-	44,694	-	-	88,941,000	Mar 31, 2023
NORTHERN TRUST CORP	0.21%	-	12,207	-	-	24,292,000	Mar 31, 2023
BLACKROCK INC.	1.25%	-	74,063	-	-	147,385,000	Mar 31, 2023
STATE STREET CORP	0.41%	-	24,443	-	-	48,397,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	86	1	1.18%	172,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	2	2	100.00%	4,000	Mar 31, 2023
FMR LLC	0.00%	-	4	4	100.00%	8,000	Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	0.15%	0.00%	8,651	3,804	78.48%	17,000	Mar 31, 2023

As of Mar 31 2023, Cocrystal Pharma's biggest institutional seller is SABBY MANAGEMENT, LLC. The company sold -0.35M shares of COCP, valued at $131.68M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.35%	-	20,728	20,728	100.00%	41,041,000	Mar 31, 2023
FMR LLC	0.00%	-	4	4	100.00%	8,000	Mar 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	2	2	100.00%	4,000	Mar 31, 2023

Cocrystal Pharma's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 20.73K shares, valued at $41.04M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-260	-100.00%	-	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	-	-18	-100.00%	-	Mar 31, 2023
PNC FINANCIAL SERVICES GROUP, INC.	-	-	-	-18	-100.00%	-	Mar 31, 2023

Cocrystal Pharma's largest sold out institutional shareholder by shares sold is JPMORGAN CHASE & CO, sold -0.26K shares, valued at -, as of undefined.

Cocrystal Pharma Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
WASATCH FUNDS TRUST	0.19%	1,791,443	-	-	Mar 31, 2024
Vericimetry Funds	0.12%	12,350	-	-	Dec 31, 2023
VANGUARD INDEX FUNDS	0.01%	3,137,666	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	772,698	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	90,909	-	-	Dec 31, 2023
SCHWAB CAPITAL TRUST	0.00%	39,234	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	344,801	76,721	28.62%	Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	7,576	-	-	Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	158,458	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	4,979	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	854	-	-	Dec 31, 2023
Dimensional ETF Trust	0.00%	308	-	-	Jan 31, 2024
iSHARES TRUST	0.00%	10,077	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	578	-	-	Dec 31, 2023

Cocrystal Pharma's largest mutual fund holder by % of total assets is "WASATCH FUNDS TRUST", owning 1.79M shares, compromising 0.19% of its total assets.

Cocrystal Pharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 22	22	-15.38%
30 Jun, 22	26	-3.70%
31 Mar, 22	27	-6.90%
31 Dec, 21	29	-27.50%
30 Sep, 21	40	2.56%
30 Jun, 21	39	25.81%
31 Mar, 21	31	10.71%
31 Dec, 20	28	21.74%
30 Sep, 20	23	15.00%
30 Jun, 20	20	-9.09%
31 Mar, 20	22	10.00%
31 Dec, 19	20	-9.09%
30 Sep, 19	22	29.41%
30 Jun, 19	17	-19.05%
31 Mar, 19	21	10.53%
31 Dec, 18	19	-17.39%
30 Sep, 18	23	9.52%
30 Jun, 18	21	90.91%
31 Mar, 18	11	-

As of 30 Sep 22, 22 institutions are holding Cocrystal Pharma's shares, representing a decrease of -15.38% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 22	13,529,382	-4.62%
30 Jun, 22	14,185,118	-0.96%
31 Mar, 22	14,323,170	-4.67%
31 Dec, 21	15,025,415	-1.68%
30 Sep, 21	15,282,542	-23.52%
30 Jun, 21	19,983,541	105.34%
31 Mar, 21	9,731,815	-4.28%
31 Dec, 20	10,167,026	-20.73%
30 Sep, 20	12,825,752	132.20%
30 Jun, 20	5,523,647	23.05%
31 Mar, 20	4,489,082	28.68%
31 Dec, 19	3,488,535	24.81%
30 Sep, 19	2,795,152	2.44%
30 Jun, 19	2,728,589	3.17%
31 Mar, 19	2,644,726	137.53%
31 Dec, 18	1,113,446	-20.37%
30 Sep, 18	1,398,291	5.45%
30 Jun, 18	1,326,028	620.95%
31 Mar, 18	183,928	-

Cocrystal Pharma (COCP) has 13.53M shares outstanding as of 30 Sep 22, down -4.62% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 22	166.15%	0.54%
30 Jun, 22	174.64%	0.56%
31 Mar, 22	176.34%	0.41%
31 Dec, 21	207.08%	0.58%
30 Sep, 21	188.15%	0.25%
30 Jun, 21	275.42%	1.03%
31 Mar, 21	163.91%	0.36%
31 Dec, 20	211.98%	0.30%
30 Sep, 20	267.41%	1.65%
30 Jun, 20	127.12%	0.76%
31 Mar, 20	129.30%	1.28%
31 Dec, 19	100.48%	0.89%
30 Sep, 19	106.07%	0.99%
30 Jun, 19	103.55%	0.95%
31 Mar, 19	104.61%	5.39%
31 Dec, 18	44.04%	1.40%
30 Sep, 18	56.08%	1.70%
30 Jun, 18	57.41%	70.07%
31 Mar, 18	9.05%	-

As of 30 Sep 22, Cocrystal Pharma is held by 166.15% institutional shareholders, representing a 0.54% growth compared to 30 Jun 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 22	7	-
30 Jun, 22	7	-
31 Mar, 22	7	-30.00%
31 Dec, 21	10	-37.50%
30 Sep, 21	16	-40.74%
30 Jun, 21	27	42.11%
31 Mar, 21	19	35.71%
31 Dec, 20	14	-17.65%
30 Sep, 20	17	70.00%
30 Jun, 20	10	-28.57%
31 Mar, 20	14	55.56%
31 Dec, 19	9	12.50%
30 Sep, 19	8	-
30 Jun, 19	8	-20.00%
31 Mar, 19	10	25.00%
31 Dec, 18	8	-27.27%
30 Sep, 18	11	-15.38%
30 Jun, 18	13	18.18%
31 Mar, 18	11	-

7 institutional shareholders have increased their position in COCP stock as of 30 Sep 22 compared to 7 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 22	4	-42.86%
30 Jun, 22	7	-22.22%
31 Mar, 22	9	50.00%
31 Dec, 21	6	-45.45%
30 Sep, 21	11	83.33%
30 Jun, 21	6	50.00%
31 Mar, 21	4	-42.86%
31 Dec, 20	7	250.00%
30 Sep, 20	2	-
30 Jun, 20	2	-
31 Mar, 20	2	-33.33%
31 Dec, 19	3	-50.00%
30 Sep, 19	6	20.00%
30 Jun, 19	5	25.00%
31 Mar, 19	4	-
31 Dec, 18	4	-42.86%
30 Sep, 18	7	250.00%
30 Jun, 18	2	-
31 Mar, 18	-	-

4 institutional shareholders have reduced their position in COCP stock as of 30 Sep 22 compared to 7 in the previous quarter (a -42.86% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 22	22	-15.38%	13,529,382	-4.62%	166.15%	0.54%	7	-	4	-42.86%
30 Jun, 22	26	-3.70%	14,185,118	-0.96%	174.64%	0.56%	7	-	7	-22.22%
31 Mar, 22	27	-6.90%	14,323,170	-4.67%	176.34%	0.41%	7	-30.00%	9	50.00%
31 Dec, 21	29	-27.50%	15,025,415	-1.68%	207.08%	0.58%	10	-37.50%	6	-45.45%
30 Sep, 21	40	2.56%	15,282,542	-23.52%	188.15%	0.25%	16	-40.74%	11	83.33%
30 Jun, 21	39	25.81%	19,983,541	105.34%	275.42%	1.03%	27	42.11%	6	50.00%
31 Mar, 21	31	10.71%	9,731,815	-4.28%	163.91%	0.36%	19	35.71%	4	-42.86%
31 Dec, 20	28	21.74%	10,167,026	-20.73%	211.98%	0.30%	14	-17.65%	7	250.00%
30 Sep, 20	23	15.00%	12,825,752	132.20%	267.41%	1.65%	17	70.00%	2	-
30 Jun, 20	20	-9.09%	5,523,647	23.05%	127.12%	0.76%	10	-28.57%	2	-
31 Mar, 20	22	10.00%	4,489,082	28.68%	129.30%	1.28%	14	55.56%	2	-33.33%
31 Dec, 19	20	-9.09%	3,488,535	24.81%	100.48%	0.89%	9	12.50%	3	-50.00%
30 Sep, 19	22	29.41%	2,795,152	2.44%	106.07%	0.99%	8	-	6	20.00%
30 Jun, 19	17	-19.05%	2,728,589	3.17%	103.55%	0.95%	8	-20.00%	5	25.00%
31 Mar, 19	21	10.53%	2,644,726	137.53%	104.61%	5.39%	10	25.00%	4	-
31 Dec, 18	19	-17.39%	1,113,446	-20.37%	44.04%	1.40%	8	-27.27%	4	-42.86%
30 Sep, 18	23	9.52%	1,398,291	5.45%	56.08%	1.70%	11	-15.38%	7	250.00%
30 Jun, 18	21	90.91%	1,326,028	620.95%	57.41%	70.07%	13	18.18%	2	-
31 Mar, 18	11	-	183,928	-	9.05%	-	11	-	-	-

Cocrystal Pharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 06, 2023	FROST PHILLIP MD ET AL	director, 10 percent owner		P-Purchase	Buy	1,015,229	$1.97	$2.00M	1,319,838

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 06, 2023	FROST PHILLIP MD ET AL	director, 10 percent owner		P-Purchase	Buy	1,015,229	$1.97	$2.00M	1,319,838

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 27, 2023	Hassan Fred	director	-		Sell	-	-	-	1,015,229

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 20, 2023	FROST PHILLIP MD ET AL	director, 10 percent owner		A-Award	Buy	19,333	$2.67	$51.62K	19,333
Jul 20, 2023	Japour Anthony J	director	-	A-Award	Buy	13,567	$2.67	$36.22K	13,567
Jul 20, 2023	Martin James Joseph	officer	Co-CEO and CFO	A-Award	Buy	30,000	$2.67	$80.10K	30,000
Jul 20, 2023	Kornberg Roger D.	director	-	A-Award	Buy	24,417	$2.67	$65.19K	24,417
Jul 20, 2023	Lee Sam	officer	President and Co-CEO	A-Award	Buy	30,000	$2.67	$80.10K	30,000
Jul 20, 2023	PFENNIGER RICHARD C JR	director	-	A-Award	Buy	7,333	$2.67	$19.58K	7,333
Jul 20, 2023	Hassan Fred	director	-	A-Award	Buy	7,333	$2.67	$19.58K	7,333
Jul 20, 2023	Rubin Steven D	director	-	A-Award	Buy	17,233	$2.67	$46.01K	17,233
Apr 27, 2023	Hassan Fred	director	-		Sell	-	-	-	1,015,229
Apr 06, 2023	FROST PHILLIP MD ET AL	director, 10 percent owner		P-Purchase	Buy	1,015,229	$1.97	$2.00M	1,319,838
Aug 03, 2022	Japour Anthony J	director		A-Award	Buy	148,000	-	-	148,000
Aug 03, 2022	Martin James Joseph	officer	Co- Interim CEO and CFO	A-Award	Buy	300,000	-	-	300,000
Aug 03, 2022	Martin James Joseph	officer	Co- Interim CEO and CFO	A-Award	Buy	300,000	$0.42	$126.00K	300,000
Aug 03, 2022	PFENNIGER RICHARD C JR	director		A-Award	Buy	80,000	-	-	80,000
Aug 03, 2022	PFENNIGER RICHARD C JR	director	-	A-Award	Buy	80,000	$0.42	$33.60K	80,000
Aug 03, 2022	FROST PHILLIP MD ET AL	director		A-Award	Buy	220,000	-	-	220,000
Aug 03, 2022	FROST PHILLIP MD ET AL	director	-	A-Award	Buy	220,000	$0.42	$92.40K	220,000
Aug 03, 2022	Rubin Steven D	director		A-Award	Buy	188,000	-	-	188,000
Aug 03, 2022	Rubin Steven D	director	-	A-Award	Buy	188,000	$0.42	$78.96K	188,000
Aug 03, 2022	Kornberg Roger D.	director		A-Award	Buy	280,000	-	-	280,000

The last insider sell of Cocrystal Pharma's stock was made by Hassan Fred on Apr 27 2023, selling - shares at - per share (valued at -). The last insider buy of COCP was made by FROST PHILLIP MD ET AL on Apr 06 2023, buying 1,015,229 shares at $1.97 per share (worth $2.00M).

Cocrystal Pharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	8	-	-
Q2 2023	1	1	100.00%
Q3 2022	7	-	-
Q3 2021	8	-	-
Q2 2021	-	1	-
Q4 2020	1	-	-
Q2 2020	7	1	700.00%
Q4 2019	3	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q3 2018	8	-	-
Q2 2018	5	2	250.00%
Q4 2017	1	-	-
Q3 2017	1	1	100.00%
Q2 2017	1	-	-
Q1 2017	-	-	-
Q4 2016	-	1	-
Q3 2016	3	-	-
Q1 2016	8	-	-
Q4 2015	4	-	-

8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cocrystal Pharma's insiders, as of Q3 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	-	-	-
Q2 2023	1	-	-
Q3 2022	-	-	-
Q3 2021	1	-	-
Q2 2021	-	1	-
Q4 2020	-	-	-
Q2 2020	-	-	-
Q4 2019	3	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q4 2017	-	-	-
Q3 2017	-	-	-
Q2 2017	-	-	-
Q1 2017	-	-	-
Q4 2016	-	1	-
Q3 2016	3	-	-
Q1 2016	8	-	-
Q4 2015	1	-	-

As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cocrystal Pharma's stocks.

Cocrystal Pharma Peer Ownership

Ticker	Company
BDRX	Biodexa Pharmaceuticals Plc
VRAX	Virax Biolabs Group Limited
QNRX	Quoin Pharmaceuticals, Ltd.
TPST	Tempest Therapeutics, Inc.
MBRX	Moleculin Biotech, Inc.
RNXT	RenovoRx, Inc.
BWV	Onconetix, Inc.
PXMD	PaxMedica, Inc. Common Stock
REVB	Revelation Biosciences, Inc.
BPTH	Bio-Path Holdings, Inc.
CYCC	Cyclacel Pharmaceuticals, Inc.
PULM	Pulmatrix, Inc.
HILS	Tharimmune, Inc.
IKNA	Ikena Oncology, Inc.
ALLR	Allarity Therapeutics, Inc.
AKTX	Akari Therapeutics, Plc
ONTX	Traws Pharma, Inc.
CBIO	Gyre Therapeutics, Inc.

COCP Ownership FAQ

Who Owns Cocrystal Pharma?

Cocrystal Pharma is owned by institutional shareholders (166.15%), insiders (30.03%), and public (-96.18%). The largest institutional shareholder of Cocrystal Pharma is VANGUARD GROUP INC (4.57% of total shares) and the top mutual fund owner is WASATCH FUNDS TRUST (0.19% of total shares).

Who are the major institutional shareholders of Cocrystal Pharma?

Cocrystal Pharma's major institutional shareholders are VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BLACKROCK INC., GEODE CAPITAL MANAGEMENT, LLC, and SABBY MANAGEMENT, LLC. The top five shareholders own together 10.12% of the company's share outstanding.

How many Cocrystal Pharma shareholders are there?

As of Sep 2022, there are 22 institutional shareholders of Cocrystal Pharma.

What percentage of Cocrystal Pharma is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 271.44K shares of Cocrystal Pharma, representing 4.57% of the company's total shares outstanding, valued at $540.18M (as of Mar 2023).

What percentage of Cocrystal Pharma is owned by RENAISSANCE TECHNOLOGIES LLC?

As of Mar 2023, RENAISSANCE TECHNOLOGIES LLC holds 119.83K shares of Cocrystal Pharma (COCP), compromising 2.02% of the company, valued at $238K.

What percentage of Cocrystal Pharma is owned by BLACKROCK INC?

BLACKROCK INC is the third largest holder of Cocrystal Pharma. The company owns 74.06K of the company's shares outstanding (worth $147.38M).